Page last updated: 2024-08-24

glutathione disulfide and Dyskeratosis Congenita, X-Linked

glutathione disulfide has been researched along with Dyskeratosis Congenita, X-Linked in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aykin-Burns, N; Buckingham, EM; Goldman, FD; Klingelhutz, AJ; Spitz, DR; Westin, ER1

Other Studies

1 other study(ies) available for glutathione disulfide and Dyskeratosis Congenita, X-Linked

ArticleYear
The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency.
    Antioxidants & redox signaling, 2011, Mar-15, Volume: 14, Issue:6

    Topics: Blotting, Western; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Dyskeratosis Congenita; Glutathione; Glutathione Disulfide; Humans; Oxidative Stress; Polymerase Chain Reaction; Signal Transduction; Telomerase; Tumor Suppressor Protein p53

2011